P4 medicine (predictive, preventive, personalized, participatory) is one of the world's most promising developments for improved, holistic and efficient healthcare.
DigiMed Bayern's goal is to guide Bavaria with a lighthouse project into this medicine of the future.
The lighthouse P4-medicine project DigiMed Bayern was launched at the end of 2018 with more than € 20 million funding by the Bavarian State Ministry of Health and Care. DigiMed Bayern combines comprehensive datasets of patients diagnosed with atherosclerotic diseases, such as coronary heart disease and stroke, or with genetic risk factors. This dataset will be further enriched with state-of-the-art multi-dimensional molecular characterization (-omics technologies) of associated sample material. For the integrative analysis of the resulting "Big Data", an ethically and legally compliant, highly secure and sustainable IT infrastructure will be fundamentally designed and implemented. Finally, patients and persons at risk will benefit from advancements in disease risk prediction, targeted prevention, diagnosis and treatment.
Managed by BioM Biotech Cluster Development GmbH
Copyright © 2019 BioM Biotech Cluster Development GmbH
Alle Rechte vorbehalten